BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 17881971)

  • 1. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.
    Bian XW; Yang SX; Chen JH; Ping YF; Zhou XD; Wang QL; Jiang XF; Gong W; Xiao HL; Du LL; Chen ZQ; Zhao W; Shi JQ; Wang JM
    Neurosurgery; 2007 Sep; 61(3):570-8; discussion 578-9. PubMed ID: 17881971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor.
    Yang SX; Chen JH; Jiang XF; Wang QL; Chen ZQ; Zhao W; Feng YH; Xin R; Shi JQ; Bian XW
    Biochem Biophys Res Commun; 2005 Sep; 335(2):523-8. PubMed ID: 16084492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma.
    Hu J; Deng X; Bian X; Li G; Tong Y; Li Y; Wang Q; Xin R; He X; Zhou G; Xie P; Li Y; Wang JM; Cao Y
    Clin Cancer Res; 2005 Jul; 11(13):4658-65. PubMed ID: 16000558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas.
    Zhou Y; Bian X; Le Y; Gong W; Hu J; Zhang X; Wang L; Iribarren P; Salcedo R; Howard OM; Farrar W; Wang JM
    J Natl Cancer Inst; 2005 Jun; 97(11):823-35. PubMed ID: 15928303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
    Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer].
    Ding YL; Zhang JL; Tang SF; Fu QY; Li ZT
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):202-5. PubMed ID: 18361822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.
    Kobayashi K; Ohnishi A; Promsuk J; Shimizu S; Kanai Y; Shiokawa Y; Nagane M
    Neurosurgery; 2008 Feb; 62(2):493-503; discussion 503-4. PubMed ID: 18382329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
    Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P
    Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.
    Ding X; He Z; Zhou K; Cheng J; Yao H; Lu D; Cai R; Jin Y; Dong B; Xu Y; Wang Y
    J Natl Cancer Inst; 2010 Jul; 102(14):1052-68. PubMed ID: 20554944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR4-transfected human umbilical cord blood-derived mesenchymal stem cells exhibit enhanced migratory capacity toward gliomas.
    Park SA; Ryu CH; Kim SM; Lim JY; Park SI; Jeong CH; Jun JA; Oh JH; Park SH; Oh W; Jeun SS
    Int J Oncol; 2011 Jan; 38(1):97-103. PubMed ID: 21109930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of antisense bcl-2 cDNA abolishes tumorigenicity and enhances chemosensitivity of human malignant glioma cells.
    Zhu CJ; Li YB; Wong MC
    J Neurosci Res; 2003 Oct; 74(1):60-6. PubMed ID: 13130506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion.
    Hong X; Jiang F; Kalkanis SN; Zhang ZG; Zhang XP; DeCarvalho AC; Katakowski M; Bobbitt K; Mikkelsen T; Chopp M
    Cancer Lett; 2006 May; 236(1):39-45. PubMed ID: 15967572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nordy inhibits cell proliferation and angiogenic factor production of malignant human glioma cells mediated by formylpeptide receptor].
    Yao XH; Ping YF; Bian XW; Chen JH; Wang QL; Jiang XF
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(7):479-84. PubMed ID: 17459229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nordy, a synthetic lipoxygenase inhibitor, inhibits the expression of formylpeptide receptor and induces differentiation of malignant glioma cells.
    Chen JH; Bian XW; Yao XH; Gong W; Hu J; Chen K; Iribarren P; Zhao W; Zhou XD
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1368-74. PubMed ID: 16516855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of chemokine receptors on uveal melanoma cells and their metastases.
    Li H; Alizadeh H; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):636-43. PubMed ID: 18235009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of stromal cell-derived factor-1 and its receptor CXCR4 on liver metastasis of human colon cancer].
    Ding YL; Fu QY; Tang SF; Zhang JL; Li ZY; Li ZT
    Zhonghua Wai Ke Za Zhi; 2009 Feb; 47(3):210-3. PubMed ID: 19563077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of CXCR4 in lung cancer metastasis and its possible mechanism].
    Su LP; Zhang JP; Xu HB; Chen J; Wang Y; Xiong SD
    Zhonghua Yi Xue Za Zhi; 2005 May; 85(17):1190-4. PubMed ID: 16029594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.
    Ehtesham M; Stevenson CB; Thompson RC
    Neurosurgery; 2008 Oct; 63(4):E820; author reply E820. PubMed ID: 18981857
    [No Abstract]   [Full Text] [Related]  

  • 19. The chemokine GRO-alpha (CXCL1) confers increased tumorigenicity to glioma cells.
    Zhou Y; Zhang J; Liu Q; Bell R; Muruve DA; Forsyth P; Arcellana-Panlilio M; Robbins S; Yong VW
    Carcinogenesis; 2005 Dec; 26(12):2058-68. PubMed ID: 16033775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relations among expression of CXCR4, histological patterns, and metastatic potential in adenoid cystic carcinoma of the head and neck.
    Zushi Y; Noguchi K; Hashitani S; Sakurai K; Segawa E; Takaoka K; Toyohara Y; Tanaka N; Kishimoto H; Urade M
    Int J Oncol; 2008 Dec; 33(6):1133-9. PubMed ID: 19020745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.